2008•Clinical Colorectal CancerRequires access

A Phase II Study of Cetuximab/Irinotecan in Patients with Heavily Pretreated Metastatic Colorectal Cancer: Predictive Value of Early Specific Toxicities

Teresa Gamucci, Fabrizio Nelli, Giovanni Cianci, Giulia Grassi, Luca Moscetti, Isabella Sperduti, Massimo Zeuli, Enrico Cortesi, Giuliana D’Auria, Camillo Francesco Pollera

Open publisher page 8 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Irinotecan, Cetuximab, Medicine, Colorectal cancer, Internal medicine, Rash, Oxaliplatin, Oncology